IBA (Ion Beam Applications), based in Louvain-la-Neuve, the world’s leading provider of proton therapy solutions for the treatment of cancer, has signed a contract with Quirónsalud, Spain’s leading hospital group and part of Germany’s Helios Group, to install a Proteus®ONE compact proton therapy solution in Madrid.
The contract covers delivery of a Proteus®ONE solution, including latest generation Pencil Beam Scanning (PBS), isocenter volumetric imaging (Cone Beam CT) capabilities and a long-term maintenance agreement. The hospital group will also benefit from Penn Medicine and IBA’s world leading proton therapy clinical education program. The hospital will be ready to start treating patients by 2019.
The typical end-user price for a Proteus®ONE system with a maintenance contract is between EUR 35 and 40 million. This will be IBA’s 18th installation of the compact single-room proton therapy solution.
Linked articles
Related articles
The set design for the Belgian pavilion in Osaka was created by walloon Dirty Monitor and inspired by Japanese art
EHP, world leader in thermal control systems for the space industry
Sagitta Biotech develops innovative vaccines to fight infectious diseases and cancer
